Total Funding
70
52
Total FundingSeries A raised
Growth Score
-3 pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
134058
Revamp Medical is an early stage medtech, developing catheter based solution for the treatment of Acute Decompensated Heart Failure (ADHF).
- Rafi Benary: Chief Technology Officer and Co-founderPast Role: EndoSpan, Chief Technology Officer
- Michael Favet: Chief Executive OfficerPast Role: NeuroPace, Chief Executive Officer
About the Company
Revamp medical was founded in 2016 with the goal of resolving one of the most urgent unmet needs in Acute Heart Failure patients. Targeting a market of >1M annual admissions in the US with a direct cost of $65B, Revamp is set to deliver an easily adoptable solution using its patented temporary catheter, Doraya™.
Revamp has a seasoned team of
professionals with a proven track record in leading multiple med-tech startups.
